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ABSTRACT
Objective: To generate estimates of the burden of
UK-acquired foodborne disease accounting for
uncertainty.
Design: A modelling study combining data from
national public health surveillance systems for
laboratory-confirmed infectious intestinal disease (IID)
and outbreaks of foodborne disease and 2 prospective,
population-based studies of IID in the community. The
underlying data sets covered the time period 1993–
2008. We used Monte Carlo simulation and a Bayesian
approach, using a systematic review to generate
Bayesian priors. We calculated point estimates with
95% credible intervals (CrI).
Setting: UK, 2009.
Outcome measures: Pathogen-specific estimates of
the number of cases, general practice (GP)
consultations and hospitalisations for foodborne
disease in the UK in 2009.
Results: Bayesian approaches gave slightly more
conservative estimates of overall health burden
(∼511 000 cases vs 566 000 cases). Campylobacter
is the most common foodborne pathogen, causing
280 400 (95% CrI 182 503–435 693) food-related
cases and 38 860 (95% CrI 27 160–55 610) GP
consultations annually. Despite this, there are only
around 562 (95% CrI 189–1330) food-related hospital
admissions due to Campylobacter, reflecting relatively
low disease severity. Salmonella causes the largest
number of hospitalisations, an estimated 2490
admissions (95% CrI 607–9631), closely followed by
Escherichia coli O157 with 2233 admissions (95% CrI
170–32 159). Other common causes of foodborne
disease include Clostridium perfringens, with an
estimated 79 570 cases annually (95% CrI
30 700–211 298) and norovirus with 74 100 cases
(95% CrI 61 150–89 660). Other viruses and protozoa
ranked much lower as causes of foodborne disease.
Conclusions: The 3 models yielded similar estimates
of the burden of foodborne illness in the UK and show
that continued reductions in Campylobacter,
Salmonella, E. coli O157, C. perfringens and norovirus
are needed to mitigate the impact of foodborne
disease.
INTRODUCTION
Food safety is a global priority.1 To have
maximum impact, the design and funding of
food safety interventions need to take
account the overall burden of foodborne
disease and the contribution made by each
pathogen. Developing better methods for esti-
mating the true burden of foodborne disease
has been the focus of international efforts for
over a decade.1–8 This is problematic for
various reasons: people usually present with
non-speciﬁc symptoms of infectious intestinal
disease (IID), only a fraction of cases are con-
ﬁrmed by laboratory testing, and not all are
reported to national public health surveil-
lance. IID then needs to be attributed to
transmission route (foodborne, waterborne,
animal-to-person, person-to-person or
environment-to-person), which can be difﬁ-
cult if robust epidemiological information is
lacking. In a recent population-based, pro-
spective study in the UK (known as the IID2
study) we found that IID affected around one
Strengths and limitations of this study
▪ This is the first burden of foodborne illness model-
ling study to incorporate empirical data and prior
information from a systematic review together with
Bayesian methodology for estimating the propor-
tion of infectious intestinal disease that is transmit-
ted through contaminated food.
▪ Our estimates are based on high-quality data
sets, including directly observed, pathogen-
specific incidence data.
▪ Our methods take full account of parameter
uncertainties.
▪ There are several data gaps which need to be
filled including pathogen-specific mortality esti-
mates, and information on morbidity in vulner-
able populations such as immunocompromised
people, older people and pregnant women.
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in four people each year (∼17 million cases in 2009).9 We
used novel methods to estimate, for each pathogen, the
proportion of IID attributable to food and the health
burden of UK-acquired foodborne disease.
METHODS
Data sources
The IID studies
Two population-based studies of IID have taken place in
the UK (box 1). The ﬁrst (IID1 study) was conducted in
England in 1993–1996,9 and the second (IID2 study)
took place across the whole of the UK in 2008–2009.10–11
Both comprised (1) a prospective cohort study of people
living in the community and (2) a prospective study of
patients presenting to general practice (GP) with symp-
toms of IID. Samples were obtained for laboratory testing
from symptomatic cases in the cohort and from patients
presenting to GP and tested using comprehensive micro-
biology algorithms.11 12 The case deﬁnitions were identi-
cal in both studies, and incidence rates of IID in the
community and GP consultation rates for IID were calcu-
lated. Data on healthcare use, captured by question-
naires, gave estimates of hospitalisation rates.
Outbreak surveillance data
The four UK national surveillance centres provided data
on general outbreaks of IID occurring between 1
January 2001 and 31 December 2008 (n=2965; table 1).
There were substantial changes to outbreak reporting in
2009. Prior to 2009 Public Health England (PHE) col-
lected data on all gastrointestinal infection outbreaks no
matter what the transmission route was, that is, food-
borne, waterborne, person to person, environment to
person and animal to person. In 2009 PHE limited the
collection of outbreak data on ‘non-foodborne out-
breaks’ to ‘gastrointestinal outbreaks including illnesses
associated with recreational water exposure, environmen-
tal exposure at outdoor events example contact with
mud, contact with animals or their faeces and outbreaks
of verocytotoxin-producing Escherichia coli (VTEC)
mediated through person-to-person transmission’. Thus
the data collected from December 2008 represented a
subset of outbreaks rather than all outbreaks. This
affected the proportion of illnesses assessed as food-
borne because the denominators of outbreaks and cases
in outbreaks changed substantially as a result of changes
in reporting deﬁnitions. This was particularly problem-
atic for pathogens such as norovirus and Cryptosporidium.
For each outbreak, information was available on the
following: outbreak setting, number of cases affected,
number of cases hospitalised, main mode(s) of transmis-
sion, pathogen identiﬁed and, for outbreaks involving
contaminated foods, the implicated food vehicle (where
this was ascertained). For this study, point source or dis-
seminated outbreaks involving contaminated food, and
outbreaks involving contaminated food with subsequent
person-to-person transmission, were considered to be
foodborne. In total, there were 446 outbreaks involving
foodborne transmission that were available for analysis.
Systematic literature review
We conducted a systematic literature review according to
the Preferred Reporting Items for Systematic Reviews
and Meta-Analyses (PRISMA) guidelines.13 We searched
four databases (MEDLINE, EMBASE, Web of Science
and FoodBase—the UK Food Standards Agency’s
research projects database). The full methodology for
our systematic review, and a summary of the results have
been reported previously.14 We also compared the list of
articles that we identiﬁed through the systematic review
with a list of case–control studies included in a separate,
independently published review of case–control study
methods for enteric infection.15 We identiﬁed 32 articles
published between 1 January 2001 and 31 December
2011 with relevant information that allowed us to deter-
mine the percentage of cases of IID attributable to food-
borne transmission (see also online supplementary
technical appendix). The Bayesian priors were based on
uniform distributions, which essentially assumed that
any value within a speciﬁed range is likely equal. The
lower and upper bounds of the distribution were deter-
mined by the lowest and highest estimates from studies
found in the literature review. So for example, the
reported range for foodborne Campylobacter was between
42% and 80%, and these percentages formed the lower
and upper bounds used for the uniform prior (see
online supplementary technical appendix).
Modelling approach
We developed a model to estimate the number of cases,
GP consultations and hospital admissions of
UK-acquired foodborne disease due to 13 major enteric
pathogens: Clostridium perfringens, Campylobacter, E. coli
O157, Listeria, Salmonella (non-typhoidal), Shigella,
Cryptosporidium, Giardia, adenovirus, astrovirus, noro-
virus, rotavirus and sapovirus. The basic model was:
Fp¼ Ncppp
Gp¼ Ngppp
Hp¼Fpgp
where Fp, Gp and Hp represent, respectively, the esti-
mated number of UK-acquired foodborne disease cases,
GP consultations or hospital admissions for pathogen
Box 1 Sample sizes in the IID1 and IID2 studies9 10
IID1, England, August 1993—January 1996:
Prospective Cohort Study: N=9776;
General Practice Presentation Study: N=4026.
IID2, UK, April 2008—August 2009:
Prospective Cohort Study: N=7033;
General Practice Presentation Study: N=991.
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p in 2009. Cp is the UK incidence of IID due to patho-
gen p and gp is the GP consultation rate for IID due to
pathogen p. The constant, N, is the mid-2009 population
of the UK. The two parameters, πp and γp, represent,
respectively, the proportion of IID cases due to pathogen
p that are transmitted through food, and the proportion
of cases due to pathogen p that are hospitalised. We
assumed that foodborne cases were equally likely to
consult a GP or be hospitalised as non-foodborne cases.
We used various data sources to inform model para-
meters. The data available for each pathogen are sum-
marised in the online supplementary technical
appendix tables A1–A3. We used two modelling
approaches: a Monte Carlo simulation approach and a
Bayesian approach. In the Monte Carlo approach, the
parameters πp and γp were deﬁned by β distributions
ﬁtted to empirical bootstrap samples of UK outbreak
data; in the Bayesian approach, these parameters were
modelled as binomial quantities and given priors
informed by published studies and hospitalisation data
from previous studies in the UK. Model details are given
in the online supplementary technical appendix.
Pathogen-specific rates of IID (cp, γp)
We obtained data from the IID2 study on population
incidence and GP consultation rates for IID, and their
associated uncertainty, for the above pathogens.10 For
Shigella, no cases were found in IID2 so we applied the
reporting ratio from IID1 (the ratio of community cases
to laboratory-conﬁrmed cases reported to national sur-
veillance) to the number of cases reported in 2009 and
divided this by the mid-2009 UK population to obtain
the overall shigellosis rate.11 Similarly, we estimated GP
consultation rates by applying the reporting ratio from
IID1 (the ratio of GP consultations to laboratory-
conﬁrmed cases reported to national surveillance) to
the number of laboratory reports in 2009. We accounted
for uncertainty in incidence estimates by sampling
100 000 times from the distribution of reporting ratios
estimated in IID1. For Listeria, no incidence data were
available from IID1 or IID2 so we used the number of
laboratory reports for listeriosis in 2009 as a conservative
population incidence estimate.
Proportion of cases transmitted through food (πp)
Estimating the proportion of cases transmitted through food
We used data on outbreaks reported to national surveil-
lance systems between January 2001 and December 2008
to estimate the proportion of cases transmitted through
food. For each pathogen, we computed empirical esti-
mates for πp by obtaining 4999 bootstrap samples of the
proportion of cases in outbreaks that resulted from food-
borne transmission. We then ﬁtted a β function to the
resulting distribution using maximum likelihood. For
Cryptosporidium and Giardia, this approach gave an
unrealistically high estimate for the proportion of cases
transmitted through food because, of the few outbreaks
that were reported, those involving foodborne transmis-
sion were larger. For these two pathogens, we used
instead the proportion of outbreaks that were foodborne
as an estimate of πp, as was done in a previous study.
5
For adenovirus and sapovirus, for which no outbreaks
were reported, we used parameters derived from analysis
of rotavirus and norovirus outbreaks respectively. For
pathogens for which all outbreaks or no outbreaks were
foodborne, we speciﬁed limits to the ﬁtted β distribu-
tions as described in the online supplementary technical
appendix. The a and b parameters from the ﬁtted
β distributions were then used in the Monte Carlo simu-
lations (see Model 1 below).
Table 1 Summary of outbreak data for food attribution by pathogen, UK 2001–2008
Foodborne outbreaks
Cases in foodborne
outbreaks
Organism Foodborne All outbreaks Per cent Cases All cases Per cent Source
Bacteria
C. perfringens 45 60 75.0 1691 1964 86.1 Outbreak surveillance
Campylobacter 31 44 70.5 373 761 49.0 Outbreak surveillance
E. coli O157 25 86 29.1 564 1041 54.2 Outbreak surveillance
Listeria 2 2 100.0 6 6 100.0 Outbreak surveillance
Salmonella 266 308 86.4 7128 7892 90.3 Outbreak surveillance
Shigella 4 11 36.4 65 310 21.0 Outbreak surveillance
Protozoa
Cryptosporidium 4 65 6.2 415 1375 30.2 Outbreak surveillance
Giardia 1 7 14.3 106 159 66.7 Outbreak surveillance
Viruses
Adenovirus – – – – – – No outbreaks reported
Astrovirus 0 18 0.0 0 283 0.0 Outbreak surveillance
Norovirus 61 2228 2.7 1500 58 855 2.5 Outbreak surveillance
Sapovirus – – – – – – No outbreaks reported
Rotavirus 1 136 0.7 30 2338 1.3 Outbreak surveillance
C. perfringens, Clostridium perfringens; E. coli, Escherichia coli.
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Prior distributions for the proportion of cases transmitted
through food (πp)
We obtained prior distributions for the πp parameters
from the systematic literature review. We divided the
retrieved articles into two categories: food attribution
studies (Group A) and others (Group B). In Group A
studies the proportion of cases transmitted through food
was estimated for several pathogens, through expert
elicitation or retrospective data reviews. Group B were
primarily pathogen-speciﬁc case–control studies or
studies using microbiological typing for source attribu-
tion. For Group A and Group B studies, we deﬁned
uniform distributions for πp, based on the minimum
and maximum estimates of the proportion of cases trans-
mitted through food in these studies, for pathogens with
at least two published studies. Where the observed pro-
portion from outbreak data fell outside the limits of this
uniform distribution, we arbitrarily allowed the lower or
upper limit of the distribution to extend by 0.1 beyond
the observed value.
Pathogen-specific hospitalisation (γp)
Data on hospitalisations were available only for out-
breaks reported in England and Wales. For each
reported outbreak, excluding those in hospitals or resi-
dential institutions, we computed the proportion of
cases hospitalised by causative organism. We based hos-
pitalisation estimates on all outbreaks with the available
data, as we found no major differences in hospitalisation
between foodborne and other outbreaks. To account for
uncertainty in these parameters, we ﬁtted β distributions
to bootstrapped data as detailed above for πp, but
additionally weighting by outbreak size (see online sup-
plementary technical appendix). For adenovirus and
sapovirus, we used parameters derived from analysis of
rotavirus and norovirus outbreaks, respectively. Bootstrap
estimates with ﬁtted β distributions by pathogen are
shown in the online supplementary technical appendix.
Prior distributions for pathogen-specific hospitalisation (γp)
We used pathogen speciﬁc, β-distributed priors for γp.
The β parameters were informed by an analysis of hospi-
talisation data from the IID1 and IID2 studies (see online
supplementary ﬁgure A1 and technical appendix).
Estimating food-related IID cases, GP consultations
and hospitalisations (Fp, Gp, Hp). We obtained estimates
of the number of foodborne cases, GP consultations and
hospitalisations using three different approaches. In
Model 1, we used the Monte Carlo simulation to draw
values at random from each parameter distribution. In
Model 2, we used a Bayesian approach that included
parameters for the prior distributions of γp from the
IID1 and IID2 studies and for πp from Group A studies
as described above. These priors were used, together
with the outbreak data, to obtain posterior distributions
for these parameters, which were then used in the
model. This model could not be applied to sapovirus,
because none of the identiﬁed studies had information
about this pathogen. Model 3 had the same structure as
Model 2, except that Bayesian priors for πp from Group
B studies were used instead. This model was applied to
Campylobacter, E. coli O157, Listeria and Salmonella, for
which sufﬁcient data from published studies were avail-
able. A full description of model parameters is given in
the online supplementary technical appendix.
For each model, we carried out 100 000 simulations,
discarding the ﬁrst 10% and retaining the model outputs
for every 10th simulation. We checked model conver-
gence graphically by plotting parameter values over time
to verify adequate mixing, plotting autocorrelograms and
comparing density plots for outcome variables by tertile
of the simulation chain. We summarised model outputs
using the median and central 95% of the posterior distri-
butions to obtain point estimates and 95% credible inter-
vals (CrI) for the number of food-related cases, GP
consultations and hospitalisations by pathogen. We con-
ducted the analyses using Stata V.12.1, WinBUGS and
Microsoft Excel software. We used the winbugsfromstata
module in Stata to carry out the simulations.16
Ethical considerations
An Ethics Committee favourable opinion was not
required. These were secondary analyses of previously
collected, publicly available data. All data sets used were
completely anonymous and there was no risk of disclo-
sure of personal data.
RESULTS
Proportion of cases attributable to foodborne transmission
Table 1 summarises the outbreak data used for estima-
ting the proportion of cases due to foodborne transmis-
sion from outbreak data. The identiﬁed studies used to
inform Bayesian uniform priors are summarised in the
online supplementary technical appendix tables A2 and
A3. Figure 1 shows the empirical bootstrap distributions
for the estimated proportion of cases due to foodborne
transmission based on outbreak data. For most patho-
gens, the β distribution provided a reasonable ﬁt to the
bootstrapped distribution, with the exception of Giardia,
for which data were sparse, and rotavirus, for which the
estimated proportion foodborne transmission was very
small. Salmonella and C. perfringens had the largest esti-
mated proportion of cases attributable to foodborne
transmission, each ∼90%. Around 50% of Campylobacter
and E. coli O157 cases were estimated to result from
foodborne transmission, although there was consider-
able uncertainty in these estimates as evidenced by the
long tails in these distributions. Foodborne transmission
accounted for <5% of norovirus cases, while ∼65% of
Giardia cases, 30% of Cryptosporidium cases and 20% of
Shigella cases were food related.
Proportion of cases hospitalised
Table 2 summarises the data sources used to inform hos-
pitalisation parameters. Figure 2 shows the estimated
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hospitalisation proportions in reported outbreaks by
pathogen, based on the medians of β distributions ﬁtted
to outbreak data. Hospitalisation was particularly high
for E. coli O157 (23%). In contrast, <2% of cases due to
C. perfringens, Campylobacter, Giardia, norovirus and rota-
virus were hospitalised.
Cases, GP consultations and hospital admissions
attributable to foodborne transmission (Model 1)
Table 3 presents estimates of food-related cases, GP con-
sultations and hospital admissions in 2009 from 100 000
Monte Carlo simulations. Campylobacter was the most
common foodborne pathogen, accounting for 286 000
food-related cases (95% CrI 131 105–532 400) and
39 750 GP consultations (95% CrI 18 890–69 540), but
ranked third as a cause of food-related hospital
admissions (1376 admissions) behind Salmonella (2536
admissions) and E. coli O157 (2141 admissions).
Foodborne norovirus accounted for 3240 GP consulta-
tions (95% CrI 1985–5162), but fewer than 500 hospital
admissions. Similarly, other pathogens such as C. perfrin-
gens and a number of the viruses, while contributing
large numbers of cases and GP consultations, were
responsible for a modest number of food-related hos-
pital admissions. It should be noted, however, that there
was a large degree of uncertainty around these esti-
mates, as demonstrated by the wide 95% CrI.
Cases, GP consultations and hospital admissions
attributable to foodborne transmission (Models 2 and 3)
Estimates of food-related cases, GP consultations and
hospital admissions based on the Bayesian approach
used in Model 2 are presented in table 4. Campylobacter
was the most common foodborne pathogen, causing
280 400 (95% CrI 182 503–435 693) food-related cases
and 38 860 (95% CrI 27 160–55 610) GP consultations
annually. Despite this, there were only 562 (95% CrI
189–1330) Campylobacter-related hospital admissions.
Salmonella caused the largest number of hospitalisations,
an estimated 2490 admissions (95% CrI 607–9631),
closely followed by E. coli O157 with 2233 admissions
(95% CrI 170–32 159). Other common causes of food-
borne disease included C. perfringens, with an estimated
79 570 cases annually (95% CrI 30 700–211 298), and
norovirus with 74 100 cases (95% CrI 61 150–89 660).
For Model 2, there were insufﬁcient data from the
studies we identiﬁed to enable estimation of foodborne
sapovirus. For Campylobacter, E. coli O157, Listeria and
Salmonella, further estimates from Model 3 are presented
in table 5. The estimates from the three different
models are compared in ﬁgure 3A–C.
Figure 1 Empirical bootstrap distributions for the estimated proportion of cases due to foodborne transmission based on
outbreak data.
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Comparing the models
In general, the results from all three approaches were
similar for food-related cases and GP consultations. For
most organisms, the Bayesian estimates from Model 2
beneﬁted from greater precision. There were differences
in the number of food-related hospital admissions esti-
mated by the Monte Carlo and Bayesian approaches for
some organisms, notably Campylobacter, rotavirus, adeno-
virus and astrovirus. The differences reﬂect discordance
between outbreak data and data from the IID studies in
terms of the hospitalisation rate for these organisms.
Where differences were observed, the Bayesian approach
gave more conservative estimates of the number of
food-related hospital admissions.
For the four pathogens with sufﬁcient data from the
literature review to generate estimates from Model 3
(Campylobacter, E. coli O157, Listeria and Salmonella), esti-
mates were similar to those from Model 2; however,
Listeria estimates carried greater uncertainty, because of
wide disagreement between the two identiﬁed studies
regarding the proportion of listeriosis attributable to
foodborne transmission. It was impossible to calculate
listeriosis hospitalisations because all reported Listeria
outbreaks occurred in hospitals.
DISCUSSION
To the best of our knowledge this is the ﬁrst study to
incorporate empirical data and prior information from a
systematic review using Bayesian methodology for estimat-
ing the proportion of IID that is transmitted through
contaminated food. Campylobacter is the most common
foodborne pathogen in the UK, causing between 182 503
and 435 693 food-related cases and between 27 160 and
55 610 GP consultations annually (based on Model 2
results). Despite this, the number of Campylobacter-related
hospital admissions is comparatively small, reﬂecting a
generally lower level of acute disease severity compared
with other pathogens. In contrast, Salmonella and E. coli
O157 cause the largest number of hospitalisations, an
estimated 2490 and 2233 admissions respectively (Model
2), although uncertainty around these estimates is high.
Other common causes of foodborne illness include C.
perfringens, responsible for nearly 80 000 cases annually
and norovirus, responsible for nearly 75 000 cases. Other
viral agents rank lower as causes of foodborne illness.
Our analysis updates previous estimates for England
and Wales in 2000 and expands on them by accounting
for uncertainty.5 Owing to substantial differences in the
analyses, the two sets of estimates are not directly com-
parable. Other studies investigating the burden of food-
borne illness caused by a wide range of pathogens have
been carried out in Australia, the USA and the
Netherlands.1 2 6 17 In the US and Australian studies
norovirus was one of the commonest causes of food-
borne disease. In the US study, it was also the second
most common cause of food-related hospital admissions.
Approximately one-quarter of norovirus IID cases in
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those two studies were attributed to foodborne transmis-
sion, whereas our estimate for the UK is <5%. A likely
reason for this discrepancy is the deﬁnitions of out-
breaks that are incorporated in the various modelling
studies. Some data sets contain only outbreaks transmit-
ted through food while others, like ours (until 2009),
contained all outbreaks of IID no matter what the route
of transmission. This means that the proportion of noro-
virus cases transmitted through food is likely to be over-
estimated in data sets that contain only outbreaks
transmitted through food.
A major strength of our analysis is the availability of dir-
ectly observed, pathogen-speciﬁc incidence data from
the recent IID2 study in the UK,10 which precludes the
need to adjust for underascertainment and requires
fewer assumptions about healthcare usage. The use of
methods to account fully for parameter uncertainties is
an additional strength, and is useful for highlighting
areas where data are sparse. This is particularly true for
hospitalisation estimates, for which there is a dearth of
reliable data. We investigated other sources of hospitali-
sation data, such as electronic records of inpatient admis-
sions. However, these data lack speciﬁc diagnostic codes
for certain key pathogens, including E. coli O157, and a
large fraction of admissions are classiﬁed under non-
speciﬁc diagnostic codes. We therefore used outbreak
data to estimate hospitalisation. A potential limitation is
that severe cases requiring hospitalisation might be more
Figure 2 Estimated
hospitalisation proportions in
reported outbreaks by pathogen,
based on the medians of
β distributions fitted to outbreak
data.
Table 3 Estimates of food-related cases, GP consultations and hospitalisations by pathogen, UK 2009 (Model 1)
Organism Cases (95% CrI) GP consultations (95% CrI)
Hospital
admissions (95% CrI)
Bacteria
C. perfringens 79 165 (29 310–208 688) 12 610 (5707–27 890) 165 (20–843)
Campylobacter 286 000 (131 105–532 400) 39 750 (18 890–69 540) 1376 (289–4607)
E. coli O157 9536 (644–146 495) 324 (36–2973) 2141 (143–33 237)
Listeria 169 (100–215) 169 (100–215) – –
Salmonella 33 640 (8286–135 798) 10 030 (4019–24 299) 2536 (608–10 400)
Shigella 1274 (90–11 990) 684 (84–2145) 32 (2–378)
Protozoa
Cryptosporidium 2035 (354–10 129) 588 (140–2010) 72 (12–395)
Giardia 11 250 (2239–52 878) 1322 (286–4960) 88 (17–415)
Viruses
Adenovirus 11 920 (3706–28 909) 987 (293–2536) 191 (51–559)
Astrovirus 2362 (594–7180) 180 (41–576) 70 (15–262)
Norovirus 73 420 (50 320–104 000) 3240 (1985–5162) 470 (270–779)
Rotavirus 14 850 (4698–35 330) 1603 (494–3856) 237 (64–688)
Sapovirus 40 770 (26 661–60 230) 2457 (1496–3947) 261 (145–445)
Total 566 391 73 944 7639
C. perfringens, Clostridium perfringens; E. coli, Escherichia coli; GP, general practice.
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reliably recorded in outbreak reports, whereas milder
cases might be missed. There might genuinely be higher
hospitalisation rates in outbreaks than sporadic cases
because of higher dose exposures or different popula-
tions might be affected in outbreaks. Alternatively, out-
breaks with more hospitalised cases might be more likely
to be investigated and reported. This would tend to over-
estimate hospitalisation rates. Such a bias is possible in
the E. coli O157 data, where estimates for hospitalisations
were considerably higher than for GP consultations.
Alternatively, the severity of this disease could mean that
cases are admitted directly to hospital without ﬁrst con-
sulting a GP. Our Bayesian models additionally incorpo-
rated prior information on hospitalisation rates from
IID1 and IID2. For most pathogens, the two types of
models gave similar results. However, the number of hos-
pitalisations in both sets of data were small, reﬂected in
the large degree of uncertainty in the estimates. For rota-
virus and astrovirus, the Bayesian model gave somewhat
lower estimates of hospital admissions, which might indi-
cate that hospitalisations for these two pathogens are
over-reported in outbreak data or that they were
underascertained in the IID studies. Additionally, out-
breaks might occur in speciﬁc age groups or individuals
with underlying conditions or be due to high-dose expos-
ure. Outbreak reports, however, contain limited informa-
tion on the populations affected.
Using outbreak data to attribute cases of IID to food-
borne transmission relies on certain assumptions, princi-
pally that outbreak cases reﬂect the epidemiology in the
wider community. Another potential limitation is that
there might be a bias towards investigation or reporting
of foodborne outbreaks compared with outbreaks trans-
mitted through other routes, like person-to-person trans-
mission. This, however, does not seem to be the case:
there has been a gradual decrease in the proportion of
reported outbreaks involving foodborne transmission,
which reﬂects both a reduction in incidence of certain
foodborne pathogens, particularly Salmonella, and
greater investigation of outbreaks in other settings, par-
ticularly viral outbreaks in hospitals and residential
institutions.18 19
Our study focused on foodborne illness burden in the
general UK population. Some pathogens, however, are a
Table 4 Estimates of food-related cases, GP consultations and hospitalisations by pathogen, UK 2009 (Model 2)
Organism Cases (95% CrI)
GP
consultations (95% CrI)
Hospital
admissions (95% CrI)
Bacteria
C. perfringens 79 570 (30 700–211 298) 12 680 (6072–27 040) 186 (38–732)
Campylobacter 280 400 (182 503–435 693) 38 860 (27 160–55 610) 562 (189–1330)
E. coli O157 9886 (748–142 198) 342 (37–3030) 2233 (170–32 159)
Listeria 183 (161–217) 183 (161–217) – –
Salmonella 33 130 (8178–128 195) 10 060 (4137–24 710) 2490 (607–9631)
Shigella 1204 (181–8142) 602 (341–1060) 33 (4–270)
Protozoa
Cryptosporidium 2773 (562–12 200) 800 (233–2386) 94 (18–436)
Giardia 7877 (1467–36 059) 883 (197–3288) 47 (4–332)
Viruses
Adenovirus 8253 (4734–13 780) 677 (345–1278) 62 (30–118)
Astrovirus 3470 (1368–9991) 262 (93–812) 11 (3–42)
Norovirus 74 100 (61 150–89 660) 3276 (2240–4729) 332 (248–440)
Rotavirus 10 295 (6049–16 730) 1102 (629–1870) 95 (48–177)
Sapovirus* – – – – – –
TOTAL 511 141 69 727 6145
*For sapovirus, no data were identified in the literature review on the proportion of cases attributable to food, so this model could not be applied.
C. perfringens, Clostridium perfringens; E. coli, Escherichia coli; GP, general practice.
Table 5 Estimates of food-related cases, GP consultations and hospitalisations by pathogen, UK 2009 (Model 3)
Organism Cases (95% CrI) GP consultations (95% CrI) Hospital admissions (95% CrI)
Campylobacter 279 900 (183 100–433 098) 38 820 (27 010–55 580) 561 (189–1343)
E. coli O157 9536 (644–146 495) 324 (36–2973) 2141 (143–33 237)
Listeria 166 (92–214) 166 (92–214) –* –
Salmonella 33 130 (8178–128 195) 10 060 (4137–24 710) 2490 (607–9631)
TOTAL 322 732 49 370 5192
*For Listeria, the number of hospital admissions could not be calculated, as all reported outbreaks occurred in hospitals.
E. coli, Escherichia coli; GP, general practice.
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particular problem among certain high-risk groups, such
as Listeria among immunocompromised patients and
pregnant women and rotavirus among children under
5 years. Our analysis was not designed to estimate
burden in these subgroups, because our data sources
contain limited information on these groups, and the
size of some of these high-risk populations is uncertain.
However, further studies to estimate burden in these
groups is warranted.
We were unable to include other relevant pathogens
such as toxoplasmosis, hepatitis A, hepatitis E and
non-O157 VTEC in our analysis, due to a lack of relevant
data in the UK. In a Dutch study Toxoplasma gondii
caused the highest foodborne disease burden as mea-
sured by disability-adjusted life years, reﬂecting the
importance of congenital toxoplasmosis.16
Our modelling approach meant we could use data
from various sources to incorporate the best available
information from the UK and elsewhere. Comparing
models with and without prior information indicates
where there is disagreement between data sources and
enables uncertainty in all the relevant parameters to be
accounted for. Uncertainty in these models reﬂects not
simply statistical uncertainty in individual parameters,
but disagreement between data sources and availability
of information from previous studies. Information from
previous studies on the proportion of IID transmitted
through food was captured using Bayesian uniform
priors. This is probably conservative, as it presupposes
that every value within the speciﬁed limits is likely equal.
For most pathogens, however, the number of available
studies was small and using more informative priors was
difﬁcult to justify. The exception was Campylobacter, for
which 14 studies contained relevant data. Even so, using
data from risk factor studies presents problems in inter-
pretation. Study design, methods and risk factors
Figure 3 (A) Comparison of estimates from Monte Carlo and Bayesian approaches—food-related cases, UK 2009 (Model 1:
Monte Carlo simulation approach; Model 2: Bayesian approach using data from published food attribution studies; Model 3:
Bayesian approach using data from published pathogen-specific studies (error bars show 95% CrI). (B) Comparison of estimates
from Monte Carlo and Bayesian approaches—food-related general practice consultations, UK 2009 (Model 1: Monte Carlo
simulation approach; Model 2: Bayesian approach using data from published food attribution studies; Model 3: Bayesian
approach using data from published pathogen-specific studies (error bars show 95% CrI)). (C) Comparison of estimates from
Monte Carlo and Bayesian approaches—food-related hospital admissions, UK 2009 (Model 1: Monte Carlo simulation approach;
Model 2: Bayesian approach using data from published food attribution studies; Model 3: Bayesian approach using data from
published pathogen-specific studies (error bars show 95% CrI)). C. perfringens, Clostridium perfringens, E. coli, Escherichia coli.
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investigated varied widely. Consequently, variability
between studies in the importance of food-related risk
factors is high. The choice of Bayesian priors in estima-
tion is necessarily a subjective process, as it depends on
analysts’ conﬁdence in the available information.
Establishment of a process to develop greater inter-
national consensus on the choice of priors for individual
pathogens could help to reﬁne future estimates. Better
baseline estimates would also inform predictions of the
likely increase in foodborne disease due to climate
change.20
We did not estimate deaths attributable to foodborne
illness, due to the lack of reliable data sources on
pathogen-speciﬁc mortality rates. Death certiﬁcates
rarely provide information on speciﬁc gastrointestinal
pathogens, while deaths in outbreaks are rare and may
not be recorded if they occur sometime after the event.
More generally, mortality estimates would be difﬁcult to
interpret. Deaths attributed to foodborne disease are
not necessarily the same as preventable deaths. More
focused epidemiological studies on mortality following
IID would be helpful.
Our estimates measure foodborne disease burden only
in the acute phase of illness. For some pathogens, the
long-term consequences of illness can add considerably to
their burden, for example E. coli O157-associated haemo-
lytic uraemic syndrome and Campylobacter-associated
Guillain-Barré syndrome.21 22 Moreover, our estimates are
based only on the number of cases of illness, and take no
account of the consequences of illness in different sectors
of the population. Further studies using additional mea-
sures of disease burden and taking into account long-term
health consequences are therefore required.
Modelling is not necessarily a substitute for acquiring
good quality primary data but it is very useful for point-
ing to important data gaps and major areas of uncer-
tainty where primary data collection might be focused.
Controlling foodborne disease is an important policy
issue. Given the burden of illness caused, there needs to
be a continued focus on reducing illness due to
Campylobacter, Salmonella, C. perfringens and norovirus.
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